382 related articles for article (PubMed ID: 9044848)
21. Progestins and breast cancer.
Pasqualini JR
Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():32-41. PubMed ID: 17943537
[TBL] [Abstract][Full Text] [Related]
22. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
23. Regression of human breast tumor xenografts in response to (E)-2'-deoxy-2'-(fluoromethylene)cytidine, an inhibitor of ribonucleoside diphosphate reductase.
Bitonti AJ; Dumont JA; Bush TL; Cashman EA; Cross-Doersen DE; Wright PS; Matthews DP; McCarthy JR; Kaplan DA
Cancer Res; 1994 Mar; 54(6):1485-90. PubMed ID: 8137252
[TBL] [Abstract][Full Text] [Related]
24. Aromatase inhibitors for treatment of breast cancer: current concepts and new perspectives.
Santen RJ
Breast Cancer Res Treat; 1986; 7 Suppl():S23-35. PubMed ID: 3527304
[TBL] [Abstract][Full Text] [Related]
25. Effect of breast cyst fluid on oestrone sulphatase activity in MCF-7 breast cancer cells.
Erbas H; Lennard TW; Lai LC
Anticancer Res; 1996; 16(2):833-6. PubMed ID: 8687137
[TBL] [Abstract][Full Text] [Related]
26. Steroid sulfatase: a new target for the endocrine therapy of breast cancer.
Stanway SJ; Delavault P; Purohit A; Woo LW; Thurieau C; Potter BV; Reed MJ
Oncologist; 2007 Apr; 12(4):370-4. PubMed ID: 17470679
[TBL] [Abstract][Full Text] [Related]
27. Anti-cancer activities of novel D-ring modified 2-substituted estrogen-3-O-sulfamates.
Leese MP; Leblond B; Newman SP; Purohit A; Reed MJ; Potter BV
J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):239-51. PubMed ID: 15862971
[TBL] [Abstract][Full Text] [Related]
28. Estrone sulfatase: probing structural requirements for substrate and inhibitor recognition.
Anderson C; Freeman J; Lucas LH; Farley M; Dalhoumi H; Widlanski TS
Biochemistry; 1997 Mar; 36(9):2586-94. PubMed ID: 9054565
[TBL] [Abstract][Full Text] [Related]
29. Role, control and expression of estrone sulfatase and 17 beta-hydroxysteroid dehydrogenase activities in human breast cancer.
Pasqualini JR
Zentralbl Gynakol; 1997; 119 Suppl 2():48-53. PubMed ID: 9361395
[TBL] [Abstract][Full Text] [Related]
30. Estrone and dehydroepiandrosterone sulfatase activities and plasma estrone sulfate levels in human breast carcinoma.
Prost O; Turrel MO; Dahan N; Craveur C; Adessi GL
Cancer Res; 1984 Feb; 44(2):661-4. PubMed ID: 6581863
[TBL] [Abstract][Full Text] [Related]
31. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC
Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629
[TBL] [Abstract][Full Text] [Related]
32. Reductive 17beta-hydroxysteroid dehydrogenases in the sulfatase pathway: critical in the cell proliferation of breast cancer.
Aka JA; Mazumdar M; Lin SX
Mol Cell Endocrinol; 2009 Mar; 301(1-2):183-90. PubMed ID: 19038308
[TBL] [Abstract][Full Text] [Related]
33. Effect of statins combined with estradiol on the proliferation of human receptor-positive and receptor-negative breast cancer cells.
Mueck AO; Seeger H; Wallwiener D
Menopause; 2003; 10(4):332-6. PubMed ID: 12851516
[TBL] [Abstract][Full Text] [Related]
34. Role of steroid sulfatase in local formation of estrogen in post-menopausal breast cancer patients.
Nakata T; Takashima S; Shiotsu Y; Murakata C; Ishida H; Akinaga S; Li PK; Sasano H; Suzuki T; Saeki T
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):455-60. PubMed ID: 14623544
[TBL] [Abstract][Full Text] [Related]
35. Involvement of estrone-3-sulfate transporters in proliferation of hormone-dependent breast cancer cells.
Nozawa T; Suzuki M; Takahashi K; Yabuuchi H; Maeda T; Tsuji A; Tamai I
J Pharmacol Exp Ther; 2004 Dec; 311(3):1032-7. PubMed ID: 15328376
[TBL] [Abstract][Full Text] [Related]
36. Differential effects of estrone and estrone-3-O-sulfamate derivatives on mitotic. Arrest, apoptosis, and microtubule assembly in human breast cancer cells.
MacCarthy-Morrogh L; Townsend PA; Purohit A; Hejaz HAM ; Potter BVL ; Reed MJ; Packham G
Cancer Res; 2000 Oct; 60(19):5441-50. PubMed ID: 11034086
[TBL] [Abstract][Full Text] [Related]
37. Estrone sulfate promotes human breast cancer cell replication and nuclear uptake of estradiol in MCF-7 cell cultures.
Santner SJ; Ohlsson-Wilhelm B; Santen RJ
Int J Cancer; 1993 Apr; 54(1):119-24. PubMed ID: 8478138
[TBL] [Abstract][Full Text] [Related]
38. The hydrolysis of estrone sulfate and dehydroepiandrosterone sulfate by MCF-7 human breast cancer cells.
MacIndoe JH
Endocrinology; 1988 Sep; 123(3):1281-7. PubMed ID: 2969800
[TBL] [Abstract][Full Text] [Related]
39. A new therapeutic strategy against hormone-dependent breast cancer: the preclinical development of a dual aromatase and sulfatase inhibitor.
Foster PA; Chander SK; Newman SP; Woo LW; Sutcliffe OB; Bubert C; Zhou D; Chen S; Potter BV; Reed MJ; Purohit A
Clin Cancer Res; 2008 Oct; 14(20):6469-77. PubMed ID: 18927286
[TBL] [Abstract][Full Text] [Related]
40. Estrogenicity, antiestrogenicity and estrone sulfatase inhibition of estrone-3-amine and estrone-3-thiol.
Selcer KW; Li PK
J Steroid Biochem Mol Biol; 1995 Mar; 52(3):281-6. PubMed ID: 7696150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
